Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Neurogene Inc. (NGNE) had Stock-Based Compensation of $8.32M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.93M |
|
$-75.14M |
|
-- |
|
$0.93M |
|
$83.53M |
|
$-82.61M |
|
$7.46M |
|
$-75.14M |
|
$-75.14M |
|
$-75.14M |
|
$-75.14M |
|
$-75.14M |
|
$-75.14M |
|
$-82.61M |
|
$-81.78M |
|
17.57M |
|
17.57M |
|
$-4.28 |
|
$-4.28 |
|
| Balance Sheet Financials | |
$315.92M |
|
$15.42M |
|
$19.81M |
|
$335.73M |
|
$15.16M |
|
$0.03M |
|
$10.20M |
|
$25.36M |
|
$310.38M |
|
$310.38M |
|
$310.38M |
|
14.86M |
|
| Cash Flow Statement Financials | |
$-70.60M |
|
$-125.26M |
|
$184.07M |
|
$148.72M |
|
$136.93M |
|
$-11.79M |
|
|
Stock-Based Compensation |
$8.32M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.84 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
100.00% |
|
-8930.27% |
|
-8930.27% |
|
-8840.76% |
|
-8123.68% |
|
-8123.68% |
|
$-71.41M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-24.21% |
|
-24.21% |
|
-22.38% |
|
-24.21% |
|
$20.89 |
|
$-4.07 |
|
$-4.02 |
|